$SNBH
SENTIENT BRANDS HOLDINGS INC.

2024 Q2 Form 10-K Financial Statement

#000173112224000645 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $0.00 $0.00 $150.00
YoY Change -100.0% -73.5%
Cost Of Revenue $0.00 $0.00 $50.00
YoY Change -100.0% -100.0% -54.13%
Gross Profit $0.00 $0.00 $100.00
YoY Change -100.0% -100.0% -78.12%
Gross Profit Margin 66.67%
Selling, General & Admin $132.9K $251.0K
YoY Change 212.39% -52.05%
% of Gross Profit 250960.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $970.00 $3.878K
YoY Change 0.0% -6.85%
% of Gross Profit 3878.0%
Operating Expenses $161.2K $132.9K $251.0K
YoY Change 264.5% 212.46% -52.05%
Operating Profit -$161.2K -$132.9K -$250.9K
YoY Change 237.06% 246.88% -52.02%
Interest Expense -$102.2K $226.9K
YoY Change 3.5% 7.09%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$235.1K -$477.7K
YoY Change 71.52% -34.98%
Income Tax
% Of Pretax Income
Net Earnings -$225.2K -$235.1K -$477.7K
YoY Change 150.98% 71.52% -34.98%
Net Earnings / Revenue -318489.33%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 64.37M shares 55.34M shares 54.81M shares
Diluted Shares Outstanding 62.38M shares 52.10M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.300K $1.300K
YoY Change 23.81% 23.81%
Cash & Equivalents $1.633K $1.299K
Short-Term Investments
Other Short-Term Assets $8.450K $8.450K
YoY Change
Inventory $150.0K $150.0K $150.0K
Prepaid Expenses $1.560K $8.453K
Receivables
Other Receivables
Total Short-Term Assets $153.2K $159.8K $159.8K
YoY Change -28.26% -33.18% -33.18%
LONG-TERM ASSETS
Property, Plant & Equipment $21.80K $23.74K $23.74K
YoY Change -15.1% -14.04% -14.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $21.80K $23.74K $23.74K
YoY Change -15.1% -14.04% -14.05%
TOTAL ASSETS
Total Short-Term Assets $153.2K $159.8K $159.8K
Total Long-Term Assets $21.80K $23.74K $23.74K
Total Assets $175.0K $183.5K $183.5K
YoY Change -26.84% -31.19% -31.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $725.1K $725.1K
YoY Change 34.22% 34.22%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.392M $1.392M
YoY Change 1.66% 1.66%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.148M $2.117M $2.117M
YoY Change 12.64% 10.87% 10.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.148M $2.117M $2.117M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.148M $2.117M $2.117M
YoY Change 12.64% 10.87% 10.87%
SHAREHOLDERS EQUITY
Retained Earnings -$4.175M -$3.533M
YoY Change 29.62% 15.63%
Common Stock $64.37K $56.14K
YoY Change 17.94% 7.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.973M -$1.934M -$1.934M
YoY Change
Total Liabilities & Shareholders Equity $175.0K $183.5K $183.5K
YoY Change -26.84% -31.19% -31.19%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$225.2K -$235.1K -$477.7K
YoY Change 150.98% 71.52% -34.98%
Depreciation, Depletion And Amortization $970.00 $3.878K
YoY Change 0.0% -6.85%
Cash From Operating Activities -$7.750K -$68.54K
YoY Change -68.89% -78.08%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $38.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.000K $68.80K
YoY Change -67.56% -68.38%
NET CHANGE
Cash From Operating Activities -7.750K -$68.54K
Cash From Investing Activities 0.000
Cash From Financing Activities 8.000K $68.80K
Net Change In Cash 250.0 $251.00
YoY Change -200.0% -100.26%
FREE CASH FLOW
Cash From Operating Activities -$7.750K -$68.54K
Capital Expenditures $0.00
Free Cash Flow -$7.750K -$68.54K
YoY Change -78.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001358633
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023 us-gaap Management Fee Expense
ManagementFeeExpense
usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022 snbh Inventory Write Down To Net Realigable Value
InventoryWriteDownToNetRealigableValue
usd
CY2022 snbh Sale Of Common Stock
SaleOfCommonStock
usd
CY2022 snbh Stock Issued For Payment To Vendor
StockIssuedForPaymentToVendor
usd
CY2022 snbh Exercise Of Common Stock Warrants
ExerciseOfCommonStockWarrants
usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
usd
CY2022 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 snbh Proceeds From Exercise Of Wants To Purchase Common Stock
ProceedsFromExerciseOfWantsToPurchaseCommonStock
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei City Area Code
CityAreaCode
646
CY2023 dei Local Phone Number
LocalPhoneNumber
202-2897
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1691996 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64370518 shares
CY2023 dei Auditor Name
AuditorName
VICTOR MOKUOLU CPA PLLC
CY2023 dei Auditor Location
AuditorLocation
Houston, Texas
CY2023 dei Auditor Firm
AuditorFirmId
6771
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1299 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1048 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8453 usd
CY2023 us-gaap Gross Profit
GrossProfit
100 usd
CY2022 us-gaap Gross Profit
GrossProfit
457 usd
CY2023Q4 snbh Net Of Reserve
NetOfReserve
63477 usd
CY2022Q4 snbh Net Of Reserve
NetOfReserve
63477 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
150000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
238016 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
159752 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
239064 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23742 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27620 usd
CY2023Q4 us-gaap Assets
Assets
183494 usd
CY2022Q4 us-gaap Assets
Assets
266684 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
725066 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
540217 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
533191 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
482896 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
859047 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
886547 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2117304 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1909660 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2117304 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1909660 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56140518 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56140518 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52420387 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52420387 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
56141 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
52421 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1542429 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1359249 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3533380 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3055646 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1933810 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1642976 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
183494 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
266684 usd
CY2023 us-gaap Revenues
Revenues
150 usd
CY2022 us-gaap Revenues
Revenues
566 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
50 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
109 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
70571 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
250959 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
523340 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-250859 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-522883 usd
CY2023 us-gaap Interest Expense
InterestExpense
226875 usd
CY2022 us-gaap Interest Expense
InterestExpense
211854 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-477734 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-734737 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.009
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.009
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.014
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.014
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54805831 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54805831 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52104223 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52104223 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-477734 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-734737 usd
CY2023 us-gaap Depreciation
Depreciation
3878 usd
CY2022 us-gaap Depreciation
Depreciation
4163 usd
CY2023 snbh Inventory Write Down To Net Realigable Value
InventoryWriteDownToNetRealigableValue
63477 usd
CY2023 snbh Stock Issued For Services Rendered
StockIssuedForServicesRendered
13900 usd
CY2022 snbh Stock Issued For Services Rendered
StockIssuedForServicesRendered
26182 usd
CY2023 snbh Sale Of Common Stock
SaleOfCommonStock
38000 usd
CY2023 snbh Stock Issued For Payment To Vendor
StockIssuedForPaymentToVendor
127000 usd
CY2023 snbh Exercise Of Common Stock Warrants
ExerciseOfCommonStockWarrants
8000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24539 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20765 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
8453 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
184849 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
370897 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68544 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-312730 usd
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
22795 usd
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
217580 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38000 usd
CY2023 snbh Proceeds From Exercise Of Wants To Purchase Common Stock
ProceedsFromExerciseOfWantsToPurchaseCommonStock
8000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68795 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
217580 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
251 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-95150 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1048 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96198 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1299 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1048 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
21052 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1642976 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13900 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38000 usd
CY2023 snbh Exercise Of Warrants To Purchase Common Stock Value
ExerciseOfWarrantsToPurchaseCommonStockValue
8000 usd
CY2023 snbh Stock Issued During Period Value Issued To Vendor
StockIssuedDuringPeriodValueIssuedToVendor
127000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-477734 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1933810 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-934421 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
26182 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-734737 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1642976 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zwbBh2WWUPpe" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_866_zgCpG7ewuiDh">Uses of estimates in the preparation of financial statements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zhha4xQHGrf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_863_zL9f12ClkYja">Reclassifications</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Certain reclassifications have been made to the 2022 presentation to make them consistent with 2023<i>.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
605817 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
520008 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
605817 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
520008 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3533380 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3055646 usd
CY2023Q4 snbh Working Capital Deficit
WorkingCapitalDeficit
1957552 usd
CY2022Q4 snbh Working Capital Deficit
WorkingCapitalDeficit
1642976 usd
CY2023Q4 snbh Net Of Reserve
NetOfReserve
63477 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
150000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
150000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
238016 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares

Files In Submission

Name View Source Status
0001731122-24-000645-index-headers.html Edgar Link pending
0001731122-24-000645-index.html Edgar Link pending
0001731122-24-000645.txt Edgar Link pending
0001731122-24-000645-xbrl.zip Edgar Link pending
e5586_10k.htm Edgar Link pending
e5586_ex31-1.htm Edgar Link pending
e5586_ex31-2.htm Edgar Link pending
e5586_ex32-1.htm Edgar Link pending
e5586_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
e5586_10k_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snbh-20231231.xsd Edgar Link pending
snbh-20231231_lab.xml Edgar Link unprocessable
snbh-20231231_pre.xml Edgar Link unprocessable
snbh-20231231_cal.xml Edgar Link unprocessable
snbh-20231231_def.xml Edgar Link unprocessable